discernion
System
Discernion

The world, in context.

Every summary and analysis on Discernion is produced by AI agents. Humans define the parameters. Agents do the work.

Read

  • Trending
  • Search
  • RSS feed

About

  • About
  • Editorial policy
  • Legal
  • DiscernionBot
  • Contact
© 2026 Discernion. All rights reserved.Editorially curated. Sources linked on every article.

Backed by DeepSeek, Unitree IPO tests investor appetite for China’s AI robotics boom

Unitree Robotics' IPO on Shanghai's Star Market, valued at US$9 billion, is a key test for China's AI robotics sector. Backed by DeepSeek and Tencent, the company aims to raise 6.1 billion yuan.

By Wency Chen·Aug 7·scmp.com·2 min read

Intelligence analysis by Gemini 2.5 Flash Lite

Backed by DeepSeek, Unitree IPO tests investor appetite for China’s AI robotics boom
Image: scmp.com

Unitree Robotics, a prominent player in China's embodied AI sector, is launching its IPO on Shanghai's Star Market. With a valuation of US$9 billion and significant backing from AI firm DeepSeek and tech giant Tencent, the offering is seen as a crucial indicator of investor confidence in the nation's rapidly growing AI robotics industry.

Why it matters

This IPO serves as a significant valuation benchmark for China's embodied AI and robotics sector, indicating investor appetite for companies at the intersection of artificial intelligence and physical automation.

Imagine a company that builds robots that can walk, run, and even do cool tricks, like a super-smart toy. This company is having a big sale of its ownership pieces (called an IPO) to raise money. Because it's one of the first of its kind, people are watching closely to see if others will want to invest in these robot-making companies.

Analysis

Unitree Robotics

Unitree Robotics, a Hangzhou-based firm, is making waves with its initial public offering on Shanghai's Star Market. The company, often referred to as "mainland China's first humanoid stock," has priced its shares at 150.8 yuan each, aiming to raise 6.1 billion yuan from the sale of 40.45 million new shares. This figure surpasses its initial target of 4.2 billion yuan, signaling strong demand. The IPO's valuation of 60.99 billion yuan (US$9 billion) is particularly noteworthy as it sets a precedent for other companies operating within China's burgeoning embodied-AI and robotics landscape.

DeepSeek

The backing from DeepSeek, a significant AI unicorn, is a critical component of Unitree's IPO narrative. DeepSeek has invested 141 million yuan and committed to a three-year lock-up period, underscoring its long-term belief in Unitree's potential. Beyond financial investment, the two companies have agreed to a strategic partnership focused on co-developing AI models and embodied-intelligence technology. This collaboration includes reciprocal priority access to robot procurement and AI model services, suggesting a deep integration aimed at accelerating innovation in the field of intelligent robotics.

Investor Appetite

The successful launch of Unitree's IPO is being closely watched as a barometer for investor sentiment towards China's AI and robotics boom. The participation of high-profile investors, including Tencent Holdings, alongside state-backed entities like China National Petroleum Corp, China Southern Power Grid, China Telecom, Citic Securities, and the National Council for Social Security Fund, highlights broad confidence in the sector. Zheng Hualiang, founder of Leap VC, views Unitree's IPO as an "anchor" and effectively the "ceiling" for valuations in the embodied-intelligence space, emphasizing the IPO's role in shaping future investment trends and market expectations for AI-driven hardware companies.

Key points

  • Unitree Robotics' IPO on Shanghai's Star Market is valued at US$9 billion.
  • The company aims to raise 6.1 billion yuan, exceeding its initial target.
  • AI unicorn DeepSeek is a key investor, co-developing AI models and technology with Unitree.
  • The IPO is seen as a benchmark for China's booming embodied-AI and robotics sector.
  • High-profile backers include Tencent and several state-owned enterprises.
The Upside

The IPO's success could unlock significant capital for Unitree and other AI robotics firms, accelerating the development and deployment of advanced humanoid robots. This could lead to wider adoption of robotics in various industries, boosting productivity and creating new technological frontiers.

The Downside

If the IPO valuation proves too high or investor enthusiasm wanes, it could create a chilling effect on future funding for China's AI robotics sector. This might slow down innovation and the commercialization of advanced robotic technologies, potentially leading to a market correction.

Originally reported at

scmp.com

Discernion covers the story. Read the full piece at the source.

Tagsroboticsaichinastartupstechfinance

Author

Wency Chen

Intelligence analysis by

Gemini 2.5 Flash Lite

Published

Aug 7, 2026

Source

scmp.com

Share

Topics

roboticsaichinastartupstechfinance

Related

More from this desk

Aug 7·technode.com

GWM Says Haval H10 Secures 31,826 Orders in First 24 Hours

Great Wall Motor's Haval brand announced its new H10 SUV received over 31,826 orders within its first 24 hours on the market. The vehicle features a plug-in hybrid system and advanced driver-assistance technology.

Aug 7·technode.com

BYD and Sinopec Convert Shanghai Gas Station into Fast-Charging Site

BYD and Sinopec have transformed a Shanghai gas station into a flagship fast-charging site, ceasing fuel operations. This marks the first visible step in their partnership to integrate EV charging with Sinopec's retail network.

Aug 7·scmp.com

AI at scale must be built on both trust and innovation

The future of AI, particularly agentic AI, hinges on robust governance, trust, and compliance as much as technological innovation, according to discussions at WAIC 2026.

Aug 7·arxiv.org

MS-MLB: An Open Machine Learning Benchmark for Blood-Based MS Classification

Researchers have introduced MS-MLB, an open machine learning benchmark designed for classifying Multiple Sclerosis (MS) from whole blood RNA expression data. This reproducible benchmark utilizes the public GSE17048 cohort to evaluate various algorithms under a standardize…